Nebula Research & Development LLC Treace Medical Concepts, Inc. Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 10,126 shares of TMCI stock, worth $63,692. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,126Holding current value
$63,692% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TMCI
# of Institutions
143Shares Held
39MCall Options Held
39.7KPut Options Held
3K-
Armistice Capital, LLC New York, NY6.21MShares$39.1 Million0.79% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$25.6 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.06MShares$19.3 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$17 Million0.0% of portfolio
-
Cibc Private Wealth Group, LLC2.29MShares$14.4 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $348M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...